This is an open labeled study to determine the response and characteristics, safety and
efficacy, of the proprietary DPCP ointment composition as a topical immunotherapeutic agent
for the treatment of extensive alopecia areata.
Phase:
Phase 3
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute